Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
4(40%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
3
30%
Ph phase_2
4
40%
Ph phase_4
1
10%
Ph phase_3
1
10%

Phase Distribution

0

Early Stage

4

Mid Stage

2

Late Stage

Phase Distribution9 total trials
Phase 2Efficacy & side effects
4(44.4%)
Phase 3Large-scale testing
1(11.1%)
Phase 4Post-market surveillance
1(11.1%)
N/ANon-phased studies
3(33.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

4

trials recruiting

Total Trials

10

all time

Status Distribution
Active(4)
Completed(1)
Other(5)

Detailed Status

unknown5
Active, not recruiting3
Completed1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
10
Active
4
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 24 (44.4%)
Phase 31 (11.1%)
Phase 41 (11.1%)
N/A3 (33.3%)

Trials by Status

active_not_recruiting330%
completed110%
recruiting110%
unknown550%

Recent Activity

4 active trials
Showing 5 of 10
recruitingnot_applicable

Total Meso-rectal Excision Versus Transanal Local Excision Followed by Radiotherapy for T2N0M0 Distal Rectal Cancer

NCT04098471
active_not_recruitingphase_2

Short-course Radiotherapy Followed by Consolidation Chemotherapy. 2021-001206-29

NCT05253846
active_not_recruiting

Transanal Total Mesorectal Excision for Rectal Cancer on Anal Physiology + Fecal Incontinence

NCT03283540
active_not_recruitingphase_2

A Study of Total Neoadjuvant Therapy for High-risk Locally Advanced Rectal Cancer

NCT04543695
unknownphase_2

Neoadjuvant Therapy for Locally Advanced Rectal Cancer With Fruquintinib, Toripalimab and SRT

NCT05763927
View all 10 trials

Clinical Trials (10)

Showing 10 of 10 trials
NCT04098471Not Applicable

Total Meso-rectal Excision Versus Transanal Local Excision Followed by Radiotherapy for T2N0M0 Distal Rectal Cancer

Recruiting
NCT05253846Phase 2

Short-course Radiotherapy Followed by Consolidation Chemotherapy. 2021-001206-29

Active Not Recruiting
NCT03283540

Transanal Total Mesorectal Excision for Rectal Cancer on Anal Physiology + Fecal Incontinence

Active Not Recruiting
NCT04543695Phase 2

A Study of Total Neoadjuvant Therapy for High-risk Locally Advanced Rectal Cancer

Active Not Recruiting
NCT05763927Phase 2

Neoadjuvant Therapy for Locally Advanced Rectal Cancer With Fruquintinib, Toripalimab and SRT

Unknown
NCT04664504Phase 2

A Prospective Phase II Study of Individualized Neoadjuvant Chemoradiotherapy for Rectal Cancer Based on Recurrence Risk

Unknown
NCT04747951Phase 4

Total Neoadjuvant Therapy in Rectal Cancer Treatment

Unknown
NCT01585727Not Applicable

Intraoperative Monitoring of the Pelvic Autonomic Nerves

Completed
NCT03177382Phase 3

Total Neoadjuvant Treatment vs. Chemoradiotherapy in Local Advanced Rectal Cancer With High Risk Factors

Unknown
NCT03071198Not Applicable

Clinical Effect of Neoadjuvant Hierarchical Treatment Based on Chemotherapy

Unknown

All 10 trials loaded

Drug Details

Intervention Type
PROCEDURE
Total Trials
10